Table 3.
Group | krel (s−1) | kdf (s−1) | P1 | P2 | P3 | |
---|---|---|---|---|---|---|
WT | ||||||
Pre‐Myk461 | 434.45±37.30 | 8.46±0.52 | 0.521±0.017 | −0.050±0.013 | 0.144±0.008 | 0.194±0.012 |
0.5 μmol/L Myk461 | 442.91±35.82 | 5.53±0.55a | 0.556±0.025 | 0.040±0.017a | 0.223±0.013a | 0.183±0.017 |
1.0 μmol/L Myk461 | 459.02±40.84 | 4.41±0.44a | 0.597±0.030 | 0.123±0.022a | 0.278±0.029a | 0.156±0.019 |
KO | ||||||
Pre‐Myk461 | 898.05±42.65b | 12.31±0.85b | 0.473±0.044 | −0.057±0.014 | 0.217±0.012b | 0.275±0.019b |
0.5 μmol/L Myk461 | 576.77±57.39a | 6.40±0.39a | 0.590±0.022a | 0.038±0.023a | 0.233±0.009 | 0.195±0.016a |
1.0 μmol/L Myk461 | 437.60±45.40a | 5.25±0.35a | 0.637±0.021a | 0.139±0.014a | 0.268±0.007a | 0.129±0.012a |
kdf, rate of XB recruitment; krel, rate of XB detachment; KO, knockout; P1, XB stiffness; P2, magnitude of XB detachment; P3, the new steady‐state force attained following a 2% stretch in muscle length; Pdf, magnitude of XB recruitment; WT, wild‐type; XB, cross‐bridge. Stretch activation amplitudes were normalized to prestretch steady‐state Ca2+‐activated force, which refers to the activation level (≈40%–45% of maximal Ca2+‐activated force) as described in the Methods section. Values are expressed as mean±SE of mean. Twelve skinned myocardial preparations (3 fibers each from 4 hearts) were used for both groups. Linear mixed model was used for data analysis with Tukey post hoc tests for multiple comparisons between groups of data.
Significantly different vs the corresponding pre‐Myk461 group (P<0.05).
Significantly different vs the corresponding WT group (P<0.05).